temafloxacin has been researched along with ciprofloxacin in 73 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (8.22) | 18.7374 |
1990's | 62 (84.93) | 18.2507 |
2000's | 4 (5.48) | 29.6817 |
2010's | 1 (1.37) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bridges, AJ; Culbertson, TP; Domagala, JM; Gambino, L; Hagen, SE; Karrick, G; Porter, K; Sanchez, JP; Sesnie, JA; Spense, FG | 1 |
Domagala, JM; Hagen, SE; Heifetz, CL; Johnson, J | 1 |
Dever, JA; Domagala, JM; Gage, JW; Gracheck, SJ; Renau, TE; Sanchez, JP; Shapiro, MA | 1 |
García-March, FJ; Jaén-Oltra, J; Pérez-Giménez, F; Salabert-Salvador, MT; Tomás-Vert, F | 1 |
Antón-Fos, GM; Duart, MJ; Mut-Ronda, S; Salabert-Salvador, MT | 1 |
Aubry, A; Cambau, E; Jarlier, V; Matrat, S; Petrella, S; Sougakoff, W | 1 |
Blaskovich, MAT; Pham, TDM; Ziora, ZM | 1 |
Philip, E; Stein, GE | 1 |
Barry, AL; Fuchs, PC; Pfaller, MA | 1 |
Bergogne-Bérézin, E; Joly-Guillou, ML | 1 |
Arai, S; Gohara, Y; Kawashima, T; Kuwano, K; Matsu-Ura, I | 1 |
Hornstein, LE | 1 |
Ganiats, TG; Norcross, WA | 1 |
Fuhr, U; Granneman, GR; Kinzig, M; Mahr, G; Muth, P; Nickel, P; Patterson, K; Sörgel, F; Stephan, U | 1 |
Hammerschlag, MR; Hyman, CL; Roblin, PM | 1 |
Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
Citron, DM; Goldstein, EJ | 1 |
Azoulay-Dupuis, E; Bauchet, J; Pocidalo, JJ; Vallée, E | 1 |
Carnegie, CM; Lindsay, G; Scorer, HJ | 1 |
Gootz, TD; Martin, BA | 1 |
Bollet, C; de Micco, P; Gevaudan, MJ; Mallet, MN | 1 |
Forstall, GJ; Knapp, CC; Washington, JA | 1 |
Bethune, L; King, A; Phillips, I | 2 |
Chodosh, S | 2 |
Davey, PG | 1 |
Jungkind, DL; Parish, LC | 1 |
Hardy, DJ | 2 |
Fuchs, PC | 1 |
Giardina, WJ | 1 |
Kinzig, M; Mahr, G; Muth, P; Naber, KG; Sorgel, F | 1 |
Wise, R | 1 |
Barry, AL; Fuchs, PC | 2 |
Azoulay-Dupuis, E; Bergogne-Bérézin, E; Pocidalo, JJ; Vallée, E | 1 |
Andrews, JM; Baldwin, DR; Honeybourne, D; Wise, R | 1 |
Kosmidis, J | 1 |
Conejo, MC; García, I; Pascual, A; Perea, EJ | 1 |
Pattyn, SR | 1 |
Aubert, G; Dorche, G; Pozzetto, B | 2 |
Adler, LP; Bednarczyk, EM; Berridge, MS; Green, JA; Leisure, GA; Little, D; Miraldi, FD; Nelson, AD; Panacek, EA | 1 |
Azoulay-Dupuis, E; Bedos, JP; Hardy, DJ; Pocidalo, JJ; Swanson, RN; Vallée, E | 1 |
Chu, DT; Clement, JJ; Hardy, DJ; Shipkowitz, NL; Swanson, RN | 1 |
Andrews, JM; Ashby, JP; Cooper, MA; Matthews, RS; Wise, R | 1 |
Bauer, JF; Elrod, L; Fornnarino, JR; Heathcote, DE; Krogh, SK; Linton, CL; Norris, BJ; Quick, JE | 1 |
Bryan, JP; Krieg, RE; Perine, PL; Sheffield, J; Wagner, K; Waters, C | 1 |
Jehl, F; Koechlin, C; Linger, L; Monteil, H | 1 |
Allen, W; Gorzynski, EA; Gutman, SI | 1 |
Chin, NX; Figueredo, VM; Neu, HC; Novelli, A | 1 |
Bodey, GP; Gooch, G; Ho, DH; LeBlanc, B; Rolston, KV | 1 |
Fernandes, PB; Swanson, RN | 1 |
Bower, RR; Chu, DT; Fernandes, PB; Hanson, CW; Hardy, DJ; Hensey, DM; Ramer, NR; Swanson, RN | 1 |
Cagni, A; Chuard, C; Lew, DP; Schrenzel, J; Vaudaux, PE | 1 |
Kaatz, GW; Larsson, AJ; Moody, JA; Rotschafer, JC; Walker, KJ; Zabinski, RA | 1 |
Sanders, CC; Thomson, KS | 2 |
Aoki, M; Goldstein, E; Kunii, O; Ono, Y | 1 |
Chin, NX; Neu, HC | 1 |
Forsgren, A; Riesbeck, K | 1 |
Phillips, I; Power, EG | 1 |
Krinke, AJ; Moody, JA; Rotschafer, JC; Vance-Bryan, K; Walker, KJ; Zabinski, RA | 1 |
Foleno, BD; Fu, KP; Lafredo, SC | 1 |
Akashi, A; Arai, S; Gohara, Y; Kuwano, K; Nishimoto, M; Oizumi, K; Takeda, K; Yamaguchi, T; Yano, T | 1 |
Ikerd, TR; Koletar, SL | 1 |
Hendrickx, AG; Hummler, H; Richter, WF | 1 |
Iakovlev, SV; Iakovlev, VP; Izotova, GN | 1 |
Morrissey, I | 1 |
Baumann-Wilschke, I; Förster, C; Rücker, M; Shakibaei, M; Stahlmann, R; Vormann, J | 1 |
Peters, G; Schumacher-Perdreau, F | 1 |
Fukuda, H; Kawamura, Y | 1 |
5 review(s) available for temafloxacin and ciprofloxacin
Article | Year |
---|---|
Quinolone antibiotics.
Topics: | 2019 |
Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review.
Topics: Aging; Anti-Infective Agents; Ciprofloxacin; Drug Interactions; Fluoroquinolones; Humans; Kidney Diseases; Liver Diseases; Quinolones; Tissue Distribution | 1991 |
Comparative penetration of selected fluoroquinolones into respiratory tract fluids and tissues.
Topics: Anti-Infective Agents; Bronchi; Ciprofloxacin; Epithelium; Fluoroquinolones; Humans; Macrophages, Alveolar; Mucous Membrane; Quinolones; Respiratory System | 1991 |
Use of quinolones for the treatment of acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Anti-Infective Agents; Bronchitis; Chronic Disease; Ciprofloxacin; Fluoroquinolones; Humans; Ofloxacin; Quinolones | 1991 |
[Pharmacokinetics of fluoroquinolones in patients with renal insufficiency].
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Ofloxacin; Pefloxacin; Quinolones; Renal Insufficiency | 1995 |
8 trial(s) available for temafloxacin and ciprofloxacin
Article | Year |
---|---|
Comparison of three-day temafloxacin with seven-day ciprofloxacin treatment of urinary tract infections in women.
Topics: Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Female; Fluoroquinolones; Humans; Middle Aged; Quinolones; Urinary Tract Infections | 1992 |
Effects of temafloxacin and ciprofloxacin on the pharmacokinetics of caffeine.
Topics: Adult; Anti-Infective Agents; Caffeine; Ciprofloxacin; Double-Blind Method; Drug Interactions; Female; Fluoroquinolones; Humans; Male; Quinolones | 1992 |
Safety and efficacy of temafloxacin versus ciprofloxacin in lower respiratory tract infections: a randomized, double-blind trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteria; Ciprofloxacin; Double-Blind Method; Drug Interactions; Female; Fluoroquinolones; Humans; Male; Middle Aged; Prospective Studies; Quinolones; Respiratory Tract Infections; Theophylline | 1992 |
Temafloxacin compared with ciprofloxacin in mild to moderate lower respiratory tract infections in ambulatory patients. A multicenter, double-blind, randomized study.
Topics: Ambulatory Care; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Female; Fluoroquinolones; Humans; Lung Diseases, Obstructive; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Quinolones; Respiratory Tract Infections | 1991 |
Efficacy of temafloxacin versus ciprofloxacin or amoxicillin for lower respiratory tract infections in smokers and the elderly.
Topics: Age Factors; Aged; Amoxicillin; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Quinolones; Respiratory Tract Infections; Smoking | 1991 |
Systemic antimicrobial therapy in skin and skin structure infections: comparison of temafloxacin and ciprofloxacin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Quinolones; Skin Diseases, Infectious | 1991 |
A double-blind study of once-daily temafloxacin in the treatment of bacterial lower respiratory tract infections.
Topics: Adolescent; Adult; Anti-Infective Agents; Bronchitis; Ciprofloxacin; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Pneumonia; Quinolones; Respiratory Tract Infections | 1991 |
Comparison of the effect of temafloxacin, ciprofloxacin, or placebo on cerebral blood flow, glucose, and oxygen metabolism in healthy subjects by means of positron emission tomography.
Topics: Adolescent; Adult; Anti-Infective Agents; Brain; Cerebrovascular Circulation; Ciprofloxacin; Deoxyglucose; Double-Blind Method; Fluoroquinolones; Glucose; Humans; Male; Oxygen; Placebos; Prospective Studies; Quinolones; Reference Values; Tomography, Emission-Computed | 1991 |
60 other study(ies) available for temafloxacin and ciprofloxacin
Article | Year |
---|---|
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
Topics: Alkylation; Aminoquinolines; Animals; Anti-Bacterial Agents; Bacterial Infections; Chemical Phenomena; Chemistry; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydroxyquinolines; Mice; Microbial Sensitivity Tests; Molecular Structure; Piperazines; Pyrrolidines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1991 |
Synthesis and biological activity of 5-alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic acids.
Topics: 4-Quinolones; Anti-Infective Agents; Chemical Phenomena; Chemistry; Gram-Negative Bacteria; Gram-Positive Bacteria; Methylation; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 1991 |
Structure-activity relationships of the quinolone antibacterials against mycobacteria: effect of structural changes at N-1 and C-7.
Topics: Anti-Bacterial Agents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Mycobacterium; Spectrophotometry, Infrared; Structure-Activity Relationship | 1996 |
Artificial neural network applied to prediction of fluorquinolone antibacterial activity by topological methods.
Topics: Algorithms; Anti-Infective Agents; Fluoroquinolones; Microbial Sensitivity Tests; Neural Networks, Computer; Structure-Activity Relationship | 2000 |
Search compounds with antimicrobial activity by applying molecular topology to selected quinolones.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Discriminant Analysis; Drug Design; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship; Quinolones | 2003 |
Expression and purification of an active form of the Mycobacterium leprae DNA gyrase and its inhibition by quinolones.
Topics: Anti-Infective Agents; DNA; DNA Gyrase; DNA, Superhelical; Enzyme Inhibitors; Mycobacterium leprae; Quinolones; Topoisomerase II Inhibitors | 2007 |
Spontaneously occurring staphylococcal mutants resistant to clinically achievable concentrations of ciprofloxacin and temafloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Quinolones; Staphylococcus aureus; Staphylococcus epidermidis | 1992 |
In-vitro activity of sparfloxacin, pefloxacin, ciprofloxacin and temafloxacin against clinical isolates of Acinetobacter spp.
Topics: Acinetobacter; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Pefloxacin; Quinolones | 1992 |
[In vitro antimicrobial activities of new quinolone antibiotics against Mycoplasma pneumoniae].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Macrolides; Mycoplasma pneumoniae; Norfloxacin; Ofloxacin; Quinolones; Tetracyclines | 1992 |
Temafloxacin vs ciprofloxacin for UTI.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Quinolones; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1992 |
Temafloxacin vs ciprofloxacin for UTI.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Quinolones; Urinary Tract Infections | 1992 |
In vitro activities of five quinolones against Chlamydia pneumoniae.
Topics: Anti-Infective Agents; Chlamydophila pneumoniae; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1992 |
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Quinolones; Streptococcus pneumoniae; Vancomycin; Virginiamycin | 1992 |
Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones | 1992 |
Kinetic disposition of temafloxacin and ciprofloxacin in a murine model of pneumococcal pneumonia. Relevance for drug efficacy.
Topics: Animals; Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Female; Fluoroquinolones; Injections, Subcutaneous; Lung; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Pneumonia, Pneumococcal; Quinolones | 1992 |
Characterization of high-level quinolone resistance in Campylobacter jejuni.
Topics: Anti-Infective Agents; Campylobacter jejuni; Ciprofloxacin; DNA Topoisomerases, Type II; DNA, Superhelical; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Norfloxacin; Quinolones; Topoisomerase II Inhibitors | 1991 |
[Intra-macrophagic activity of antibiotics combinations against Mycobacterium marinum].
Topics: Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Erythromycin; Ethambutol; Fluoroquinolones; Humans; In Vitro Techniques; Macrophages; Minocycline; Mycobacterium; Quinolones; Rifabutin; Rifamycins | 1991 |
Activity of new quinolones against ciprofloxacin-resistant staphylococci.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones; Staphylococcus | 1991 |
The in-vitro activity of temafloxacin compared with other antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Species Specificity | 1991 |
Activity of temafloxacin and other fluoroquinolones against typical and atypical community-acquired respiratory tract pathogens.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Respiratory Tract Infections | 1991 |
In vitro activity of temafloxacin against gram-positive cocci including methicillin-resistant Staphylococcus aureus.
Topics: Anti-Infective Agents; Ciprofloxacin; Enterococcus; Fluoroquinolones; Gram-Positive Cocci; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Staphylococcus aureus; Streptococcus | 1991 |
In vitro activity of temafloxacin against gram-negative bacteria: an overview.
Topics: Anti-Infective Agents; Campylobacter; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Respiratory Tract Infections; Sexually Transmitted Diseases, Bacterial | 1991 |
Assessment of temafloxacin neurotoxicity in rodents.
Topics: Animals; Anti-Infective Agents; Central Nervous System; Ciprofloxacin; Enoxacin; Fluoroquinolones; Male; Mice; Mice, Inbred ICR; Motor Activity; Oxolinic Acid; Phenylbutyrates; Quinolones; Rats; Rats, Inbred Strains; Seizures | 1991 |
Anti-staphylococcal activity of temafloxacin, ciprofloxacin, ofloxacin and enoxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Oxacillin; Penicillin Resistance; Quinolones; Staphylococcal Infections; Staphylococcus | 1991 |
The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin.
Topics: Anti-Infective Agents; Bacteria; Bacteria, Aerobic; Bacteria, Anaerobic; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Quinolones | 1991 |
Pharmacokinetics of four fluoroquinolones in an animal model of infected lung.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Fluoroquinolones; Lung Diseases; Mice; Mice, Inbred Strains; Ofloxacin; Pneumococcal Infections; Quinolones; Streptococcus pneumoniae | 1991 |
Comparative pharmacokinetic disposition of fluoroquinolones in the lung.
Topics: Administration, Oral; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Injections, Intravenous; Lung; Quinolones | 1991 |
Fluorometric and high-performance liquid chromatographic measurement of quinolone uptake by human neutrophils.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Fleroxacin; Fluorescence; Fluoroquinolones; Humans; Neutrophils; Norfloxacin; Ofloxacin; Quinolones | 1991 |
Cross-resistance and cross-susceptibility between fluoroquinolone agents.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Predictive Value of Tests; Quinolones | 1991 |
Anti-Mycobacterium leprae activity of several quinolones studied in the mouse.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Leprosy; Mice; Mycobacterium leprae; Quinolones | 1991 |
[In vitro bactericidal effect of temafloxacin and tosufloxacin against streptococci].
Topics: Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Enterococcus faecalis; Enterococcus faecium; Fluoroquinolones; In Vitro Techniques; Naphthyridines; Pefloxacin; Quinolones; Streptococcus; Streptococcus agalactiae; Streptococcus bovis; Streptococcus pneumoniae; Streptococcus pyogenes; Streptococcus sanguis | 1991 |
[In vitro effect of new fluoroquinolones and betalactamines combinations against enterococci].
Topics: Amoxicillin; Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enterococcus faecalis; Fluoroquinolones; Imipenem; In Vitro Techniques; Naphthyridines; Piperacillin; Quinolones | 1991 |
Antipneumococcal activity of ciprofloxacin, ofloxacin, and temafloxacin in an experimental mouse pneumonia model at various stages of the disease.
Topics: Amoxicillin; Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Erythromycin; Female; Fluoroquinolones; Lung; Mice; Mice, Inbred C57BL; Ofloxacin; Pneumonia, Pneumococcal; Quinolones; Sepsis; Streptococcus pneumoniae | 1991 |
Activity of temafloxacin against respiratory pathogens.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Cells, Cultured; Ciprofloxacin; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Gerbillinae; Gram-Positive Bacteria; Guinea Pigs; Male; Mice; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Respiratory Tract Infections | 1991 |
In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Blood Proteins; Ciprofloxacin; Fluoroquinolones; Humans; Lactams; Microbial Sensitivity Tests; Protein Binding; Quinolones | 1990 |
Determination of temafloxacin, sarafloxacin, and difloxacin in bulk drug and dosage forms by high-performance liquid chromatography.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Fluoroquinolones; Quinolones; Solubility; Spectrophotometry, Ultraviolet | 1990 |
In vitro activities of tosufloxacin, temafloxacin, and A-56620 against pathogens of diarrhea.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Diarrhea; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Quinolones | 1990 |
High-performance liquid chromatography for the determination of three new fluoroquinolones, fleroxacin, temafloxacin and A-64730, in biological fluids.
Topics: Anti-Infective Agents; Bile; Chromatography, High Pressure Liquid; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Humans; Molecular Structure; Naphthyridines; Quinolones; Spectrometry, Fluorescence | 1989 |
Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Enoxacin; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Mycobacterium; Pefloxacin; Quinolones | 1989 |
In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent.
Topics: Anti-Bacterial Agents; Cefotaxime; Chemical Phenomena; Chemistry; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Hydrogen-Ion Concentration; Imipenem; Magnesium; Ofloxacin; Oxazines; Pseudomonas; Quinolines; Quinolones; Thienamycins | 1988 |
Comparative in vitro activity of the new difluoro-quinolone temafloxacin (A-62254) against bacterial isolates from cancer patients.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Neoplasms; Quinolones; Staphylococcus; Streptococcus | 1988 |
Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones | 1988 |
Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Female; Fluoroquinolones; Hydrogen-Ion Concentration; Mice; Microbial Sensitivity Tests; Pyelonephritis; Quinolines; Quinolones | 1987 |
Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Foreign Bodies; Guinea Pigs; Methicillin Resistance; Microbial Sensitivity Tests; Quinolones; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1995 |
Effect of aerobic and anaerobic environments on antistaphylococcal activities of five fluoroquinolones.
Topics: Anaerobiosis; Anti-Infective Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Ciprofloxacin; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Staphylococcus aureus | 1995 |
Dissociated resistance among fluoroquinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Mutation; Ofloxacin; Piperazines; Quinolones | 1994 |
Effect of newer quinolones on the extra- and intra-cellular chemiluminescence response of human polymorphonuclear leucocytes.
Topics: Anti-Infective Agents; Ciprofloxacin; Extracellular Space; Fluoroquinolones; Humans; Luminescent Measurements; Neutrophils; Ofloxacin; Quinolones; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Zymosan | 1994 |
In vitro activity of the new fluoroquinolone CP-99,219.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Quinolones | 1994 |
Limited effects of temafloxacin compared with ciprofloxacin on T-lymphocyte function.
Topics: Anti-Infective Agents; Autoradiography; Blotting, Northern; Cells, Cultured; Ciprofloxacin; Fluoroquinolones; Gene Expression; Humans; In Vitro Techniques; Interferon-gamma; Interleukin-2; Phytohemagglutinins; Quinolones; RNA, Messenger; T-Lymphocytes; Thymidine | 1994 |
Correlation between umuC induction and Salmonella mutagenicity assay for quinolone antimicrobial agents.
Topics: Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; DNA-Directed DNA Polymerase; Enoxacin; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Gene Expression Regulation, Bacterial; Mutagenicity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Quinolones; Salmonella typhimurium; SOS Response, Genetics; Species Specificity | 1993 |
Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system.
Topics: Anaerobiosis; Anti-Infective Agents; Bacteroides fragilis; Cefotetan; Ciprofloxacin; Colony Count, Microbial; Culture Media; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones | 1993 |
Induction of resistance of Streptococcus pneumoniae to quinolones in vitro.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Levofloxacin; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Quinolones; Streptococcus pneumoniae | 1993 |
Effects of new quinolones on Mycoplasma pneumoniae-infected hamsters.
Topics: Animals; Anti-Infective Agents; Antibodies, Bacterial; Ciprofloxacin; Cricetinae; Female; Fluoroquinolones; Half-Life; Humans; Lung; Mesocricetus; Mycoplasma pneumoniae; Ofloxacin; Pneumonia, Mycoplasma; Quinolones | 1993 |
In-vitro activity of ciprofloxacin, temafloxacin, azithromycin, clarithromycin and metronidazole against Giardia lamblia.
Topics: Animals; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Erythromycin; Fluoroquinolones; Giardia lamblia; Metronidazole; Microbial Sensitivity Tests; Quinolones | 1993 |
Developmental toxicity of fleroxacin and comparative pharmacokinetics of four fluoroquinolones in the cynomolgus macaque (Macaca fascicularis).
Topics: Administration, Oral; Animals; Anti-Infective Agents; Ciprofloxacin; Embryo, Mammalian; Female; Fleroxacin; Fluoroquinolones; Macaca fascicularis; Norfloxacin; Pregnancy; Pregnancy, Animal; Quinolones | 1993 |
Bactericidal index: a new way to assess quinolone bactericidal activity in vitro.
Topics: Anti-Infective Agents; Ciprofloxacin; Enterococcus faecalis; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones | 1997 |
Effects of fluoroquinolones and magnesium deficiency in murine limb bud cultures.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Embryo, Mammalian; Embryonic and Fetal Development; Extremities; Fleroxacin; Fluoroquinolones; Magnesium Deficiency; Mice; Microscopy, Electron; Ofloxacin; Pefloxacin; Quinolones | 1998 |
The effects of increasing levels of quinolone resistance on in-vitro activity of four quinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Ofloxacin; Quinolones | 1998 |
In-vitro activity of three fluoroquinolones, cefotaxime and clindamycin against staphylococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Clindamycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Staphylococcal Infections; Staphylococcus | 1995 |
[Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; beta-Alanine; Biphenyl Compounds; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Convulsants; Drug Combinations; Drug Interactions; Enoxacin; Fleroxacin; Fluoroquinolones; Imipenem; Injections, Intravenous; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Norfloxacin; Oxazines; Penicillin G; Quinolones; Seizures; Thienamycins | 2002 |